What is Keeps Biopharma Inc.'s (256940.KQ) StockRank?

MoatMap's StockRank for Keeps Biopharma Inc. (256940.KQ) is 0/100, with a Strong Sell signal. This is a composite score combining Quality (19), Value (21), and Momentum (10) factor ranks across MoatMap's 20,000+ stock universe.

Does Keeps Biopharma Inc. have an economic moat?

Keeps Biopharma Inc. (256940.KQ) has a Quality factor score of 19/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Keeps Biopharma Inc. a buy, hold, or sell?

MoatMap's current signal for Keeps Biopharma Inc. (256940.KQ) is Strong Sell, based on a StockRank of 0/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Keeps Biopharma Inc. in?

Keeps Biopharma Inc. (256940.KQ) operates in the Consumer Defensive sector, specifically the Household & Personal Products industry (South Korea).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

256940.KQ

STRONG SELLGet insider-trade alerts

Keeps Biopharma Inc. · Consumer Defensive · South Korea · $72M · Avg Vol: $239K/d

StockRank

P/E (TTM)

—

ROE

—

D/E

1.1x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

COMPANY DESCRIPTION

Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	9.5M	60.0M	83.1M	110.8M	126.6%
EPS	-0.40	0.14	0.04	-0.33	-71.9%
Shares	18.7M	18.7M	18.7M	20.1M	+7.1%
Debt	18.8M	31.5M	36.3M	60.3M	47.6%
Equity	34.6M	37.3M	32.7M	40.4M	5.3%
Op CF	-0.6M	-37,217	3.1M	-9.7M	—
Inv CF	-6.1M	-18.0M	-14.5M	-26.3M	—
Fin CF	-2.1M	5.3M	20.8M	38.1M	—

PRICE (1Y)-17.5%

SMA 50SMA 200

$3.54

RSI (14)

39.6

52W High

$14.43

From 52W High

0.2%

SCORE BREAKDOWN

Quality

ROIC

-3.1%8.0

ROE

—N/A

GP/Assets

2.5%2.3

Op. Margin

-1.1%10.3

FCF/Assets

-21.3%2.0

Piotroski

21.1

Int. Cover

-0.6x8.8

D/E Ratio

1.11x18.9

Current Ratio

4.16x90.1

Value

P/E (TTM)

—N/A

EV/EBITDA

150.0x0.7

P/FCF

—N/A

P/B

1.8x44.4

P/S

6.4x4.7

Div Yield

—N/A

Momentum

52W High %

25%2.0

RS 6M

-157%0.2

SMA 50/200

0.78x6.7

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$72M

P/E (Forward)

—

Gross Margin

33.9%

SECTOR PEERS

Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of 256940.KQ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
256940.KQ	Keeps Biopharma Inc.(you)	$72M	0	STRONG SELL
025620.KS	Cha AI Healthcare Co., Ltd.	$68M	0	STRONG SELL
123690.KS	Hankook Cosmetics Co., Ltd.	$62M	8	STRONG SELL
012690.KS	Monalisa Co., Ltd	$60M	9	STRONG SELL
003350.KS	Hankook Cosmetics Manufacturing Co., Ltd	$86M	24	SELL
214420.KS	Tonymoly Co., Ltd	$71M	29	SELL
265740.KQ	NFC Corporation	$60M	27	SELL
352480.KQ	C&C International Co., Ltd.	$177M	22	SELL
024720.KS	Kolmar Holdings Co.,Ltd.	$164M	28	SELL
123330.KQ	Genic Co., Ltd.	$117M	50	HOLD

Peer medians: ROE 5.3% · P/E 10.5x · Gross margin 26.4%

Keeps Biopharma Inc. (256940.KQ) — Stock Score Summary

Keeps Biopharma Inc. (256940.KQ) has a MoatMap StockRank of 0/100 based on Quality (19/100), Value (21/100), and Momentum (10/100) factor scores. The current signal is STRONG SELL.

Key Financial Metrics

Price	$3.54
Market Cap	$72M
Price/Book	1.76
Return on Invested Capital	-3.1%
Debt/Equity	111.20
Gross Margin	33.9%
Operating Margin	-1.1%
Revenue Growth	46.2%
Free Cash Flow	$-33M

Keeps Biopharma Inc. operates in the Household & Personal Products industry, part of the Consumer Defensive sector (South Korea).

Frequently Asked Questions

What is Keeps Biopharma Inc.’s (256940.KQ) StockRank?: MoatMap’s StockRank for Keeps Biopharma Inc. (256940.KQ) is 0/100, with a Strong Sell signal. It is a composite of Quality (19), Value (21), and Momentum (10) factor ranks across MoatMap’s 20,000+ stock universe.
Does Keeps Biopharma Inc. have an economic moat?: Keeps Biopharma Inc. (256940.KQ) has a Quality factor score of 19/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Keeps Biopharma Inc. a buy, hold, or sell?: MoatMap’s current signal for Keeps Biopharma Inc. (256940.KQ) is Strong Sell, based on a StockRank of 0/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Keeps Biopharma Inc. in?: Keeps Biopharma Inc. (256940.KQ) operates in the Consumer Defensive sector, specifically the Household & Personal Products industry (South Korea).